Recurrence: all 3,523 studies
Page 33 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam RadiotherapyCompletedNCT00604526Phase 1
- Thalidomide Versus Bortezomib in Melphalan Refractory MyelomaCompletedNCT00602511Phase 3
- Isoflavone in Prostate-specific Antigen Recurrent Prostate CancerCompletedNCT00596895Phase 2
- Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple MyelomaCompletedNCT00594126Phase 1
- A Phase I Trial of ZIO-101 in Hematologic CancersCompletedNCT00592046Phase 1
- Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)CompletedNCT00587873Phase 2
- Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder PainCompletedNCT00587626Phase 2
- Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantCompletedNCT00569283Phase 1
- Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative ResectionStatus unknownNCT00561522Phase 2/3
- A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic LeukemiaCompletedNCT00559091Phase 2
- Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00557206Phase 2
- Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid TumorsCompletedNCT00555724Phase 1
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT00554827Phase 1
- High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00544570Not applicable
- Bacterial Vaginosis; A Randomized Trial to Reduce RecurrenceCompletedNCT00542074Not applicable
- A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant GliomaCompletedNCT00539344Phase 1
- SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma MultiformeStatus unknownNCT00535379Phase 2
- Decrease of Recurrent PancreatitisCompletedNCT00534534Not applicable
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent GlioblastomaStatus unknownNCT00521482Phase 2
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseCompletedNCT00521430Not applicable
- Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior TreatmentCompletedNCT00519792Phase 1
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- Curettage Versus Excision in Nodular and Superficial Basal Cell CarcinomasSuspendedNCT00515970Not applicable
- Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGCStatus unknownNCT00510107Phase 2
- Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyCompletedNCT00509691Phase 1
- Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent LymphomaCompletedNCT00509379Phase 2
- Bortezomib and High-dose Melphalan at Myeloma RelapseStatus unknownNCT00508209Phase 2
- Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer PatientsTerminatedNCT00504699Not applicable
- A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein SurgeryTerminatedNCT00500669Phase 3
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
- Anal Fistula Plug for High-type Anal FistulaeTerminatedNCT00487071Not applicable
- Safety Study of Nifurtimox for Relapsed or Refractory NeuroblastomaCompletedNCT00486564Phase 1
- Prospective Randomized Trial of Hand-assisted Laparoscopic Right Hemicolectomy vs Total Laparoscopic Right HemicolectomyCompletedNCT00485251Phase 4
- Platinum-Resistant, Recurrent Epithelial Ovarian CancerWithdrawnNCT00484666
- A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for MyelosuppressionCompletedNCT00482261Phase 2
- Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?CompletedNCT00478348Not applicable
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT00466986Phase 2
- Fertility Surgery, Prospective AnalysisStatus unknownNCT00463398
- Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard TherapyCompletedNCT00463203Phase 2
- Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance DiseaseStatus unknownNCT00462189Phase 1
- Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaStatus unknownNCT00460681Phase 3
- Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance DiseaseStatus unknownNCT00457860Phase 1
- Divalproex vs. Lamotrigine for Bipolar DisorderTerminatedNCT00451542
- EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsCompletedNCT00448305Phase 2
- Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)CompletedNCT00444444
- "The Evaluation of Stimulant Withdrawal"WithdrawnNCT00442923Phase 2
- Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical RadiotherapyCompletedNCT00439751Phase 3
- Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)Status unknownNCT00437177Phase 2
- Study of Atiprimod Treatment for Patients With Advanced CancerTerminatedNCT00430014Phase 1
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseNo longer availableNCT00423826
- A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic LeukemiaCompletedNCT00419250Phase 1
- Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's LymphomaStatus unknownNCT00417014Not applicable
- Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's LymphomaStatus unknownNCT00416377Not applicable
- Study of Azacitidine to Treat Relapsed or Refractory Multiple MyelomaTerminatedNCT00412919Phase 2
- Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.WithdrawnNCT00408967Phase 2
- Efficacy of SU 011248 in Head And Neck CarcinomaTerminatedNCT00408252Phase 2
- A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic MalignanciesCompletedNCT00405743Phase 1/2
- Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for CancerWithdrawnNCT00402935
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinCompletedNCT00401635Phase 2
- Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma PatientsCompletedNCT00401011Phase 1/2
- DAHANCA 20 Palliative Radiotherapy for Head and Neck CancerCompletedNCT00400426Phase 2
- PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersCompletedNCT00399334
- A Randomized Trial of Surgical Treatments for Vulvar and Vaginal DysplasiaCompletedNCT00394758Phase 3
- Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell LymphomaCompletedNCT00394693Phase 2
- Safety and Efficacy of Fludarabine and Cyclophosphamide + RituximabCompletedNCT00393107Phase 2
- Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWithdrawnNCT00386516Phase 2
- Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHLStatus unknownNCT00385125Phase 2
- Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00384150Phase 3
- Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast PhaseCompletedNCT00383474Phase 1
- Phase I Using Velcade & Idarubicin in Elderly and Relapsed AMLCompletedNCT00382954Phase 1
- RCT of a Written Action Plan vs. Usual Care in Children With Acute AsthmaCompletedNCT00381355Phase 4
- Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)CompletedNCT00379470Phase 3
- Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWithdrawnNCT00378781Not applicable
- Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLCTerminatedNCT00378404Phase 1
- Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant GliomaWithdrawnNCT00378235Phase 1/2
- Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell CancerCompletedNCT00371553Phase 2
- Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian CancerCompletedNCT00368420
- Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Active, not recruitingNCT00368082Phase 1
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC PatientsStatus unknownNCT00364962
- Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AMLCompletedNCT00363974Phase 1/2
- A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00363636Phase 3
- Glycemic Relapse Prevention: Maintenance Dose AssessmentCompletedNCT00362193Phase 4
- Topotecan Pharmacokinetic Characterization StudyCompletedNCT00361803Phase 1
- hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)CompletedNCT00361699Phase 3
- Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)CompletedNCT00361530Phase 3
- Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory LymphomaCompletedNCT00359086Phase 2
- Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's LymphomaTerminatedNCT00358982Phase 2
- Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With SchizophreniaCompletedNCT00358852
- Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantCompletedNCT00357084Phase 2
- A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.CompletedNCT00354146Phase 2
- Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal GraftCompletedNCT00353535Phase 1
- A Study of ATN-224 and Bortezomib in Patients With Multiple MyelomaTerminatedNCT00352742Phase 1/2
- Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesCompletedNCT00351975Phase 1
- A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)CompletedNCT00349596Phase 1
- Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid LeukemiaCompletedNCT00342316Not applicable